Detalhe da pesquisa
1.
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Ann Surg Oncol
; 30(2): 1099-1109, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305992
2.
TP53 mutations in head and neck cancer.
Mol Carcinog
; 61(4): 385-391, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218075
3.
GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.
Lab Invest
; 100(1): 16-26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292541
4.
Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma.
Oncologist
; 23(9): 1004-e102, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769385
5.
Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.
Hum Genet
; 134(5): 497-507, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108461
6.
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Lancet Oncol
; 14(8): 697-710, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23746666
7.
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.
Eur J Cancer
; 199: 113509, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215573
8.
Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancer.
Eur J Surg Oncol
; 50(7): 108389, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728962
9.
Is open surgery for head and neck cancers truly declining?
Eur Arch Otorhinolaryngol
; 270(11): 2793-802, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23283241
10.
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Cancer
; 117(15): 3374-82, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21246525
11.
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.
BMC Cancer
; 11: 176, 2011 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21586140
12.
HPV-associated head and neck cancer: a virus-related cancer epidemic.
Lancet Oncol
; 11(8): 781-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20451455
13.
A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma.
Eur J Cancer
; 153: 109-122, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153713
14.
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
Oral Oncol
; 123: 105620, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34798575
15.
Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Curr Opin Oncol
; 22(3): 206-11, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20216313
16.
When is chemotherapy in head and neck squamous cell carcinoma not indicated?
Eur Arch Otorhinolaryngol
; 272(4): 781-787, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525999
17.
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.
Lancet Oncol
; 10(11): 1086-92, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19880062
18.
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
Cancer Med
; 9(23): 8884-8894, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040481
19.
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
J Clin Oncol
; 37(34): 3266-3274, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618129
20.
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature.
Crit Rev Oncol Hematol
; 137: 84-91, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31014517